Intravitreal bevacizumab injection for chronic central serous chorioretinopathy.
Li
Xiu-juan
XJ
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China. yankeyisheng@yeah.net
Zhang
Jin-song
JS
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000188:drug therapy*; D006801:Humans; D058449:Intravitreal Injections / Q000379:methods*; D008297:Male
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab